They also postulated a greater role for innate and adaptive cellular immunity than for humoral immunity because IgM or IgG neutralizing antibody declines faster in asymptomatic COVID-19 than in symptomatic cases (Chen et al., 2021). The gene discussed is CD40LG; the disease is COVID-19.